Trabecular bone loss after admistration of the second-generation antipsychotic risperidone is independent of weight gain (2012)
- Authors:
- Autor USP: PAULA, FRANCISCO JOSE ALBUQUERQUE DE - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bone.2011.08.005
- Subjects: ANTIPSICÓTICOS (EFEITOS ADVERSOS); DENSIDADE ÓSSEA; OSSO E OSSOS; MORFOMETRIA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2012
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MOTYL, Katherine J. et al. Trabecular bone loss after admistration of the second-generation antipsychotic risperidone is independent of weight gain. Bone, v. 50, n. 2, p. 490-498, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.bone.2011.08.005. Acesso em: 25 jan. 2026. -
APA
Motyl, K. J., Dick-de-Paula, I., Maloney, A. E., Lotinum, S., Bornstein, S., Paula, F. J. A. de, et al. (2012). Trabecular bone loss after admistration of the second-generation antipsychotic risperidone is independent of weight gain. Bone, 50( 2), 490-498. doi:10.1016/j.bone.2011.08.005 -
NLM
Motyl KJ, Dick-de-Paula I, Maloney AE, Lotinum S, Bornstein S, Paula FJA de, Baron R, Kouseknecht KL, Rosen CJ. Trabecular bone loss after admistration of the second-generation antipsychotic risperidone is independent of weight gain [Internet]. Bone. 2012 ; 50( 2): 490-498.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1016/j.bone.2011.08.005 -
Vancouver
Motyl KJ, Dick-de-Paula I, Maloney AE, Lotinum S, Bornstein S, Paula FJA de, Baron R, Kouseknecht KL, Rosen CJ. Trabecular bone loss after admistration of the second-generation antipsychotic risperidone is independent of weight gain [Internet]. Bone. 2012 ; 50( 2): 490-498.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1016/j.bone.2011.08.005 - Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-ter GH treatment on bone in adults with a mutation in the GHRH-receptor gene
- Comportamento metabolico do tecido muscular em individuos com hiperprolactinemia e em mulheres com hiperandrogenismo por hiperplasia adrenal congenita
- VDR haploinsuficiency impacts body composition and skeletal acquisition in a gender-specific manner
- Osteoporosis
- Heterozygosity in the VTR gene influences body composition more than bone mass
- Developing drugs to treat osteoporosis: lessons learned?
- Influence of primary hypoparathyroidism (PHp) on bone mineral density (BMD) and vertebral morphometry
- Effect of treatment with depot GH on bone remodeling and heel ultrasonometry in Dwarfism due to mutation in the GHRH-R gene
- The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance
- Deficiência isolada do hormônio de crescimento e metabolismo ósseo
Informações sobre o DOI: 10.1016/j.bone.2011.08.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
